Evidence map›Paper›PMID 28793337›Full record

ArticlePloS one2017

Assessment of gold nanoparticles on human peripheral blood cells by metabolic profiling with 1H-NMR spectroscopy, a novel translational approach on a patient-specific basis.

Martina Palomino-Schätzlein, Hermenegildo García, Patricia Gutiérrez-Carcedo, Antonio Pineda-Lucena, José Raul Herance

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Martina Palomino-SchätzleinLaboratorio de Bioquímica Estructural, Centro de Investigación Príncipe Felipe, Valencia, Spain.
Hermenegildo GarcíaInstituto Universitario de Tecnología Química CSIC-UPV, Valencia, Spain.
Patricia Gutiérrez-CarcedoGrup de Recerca en Imatge Mèdica Molecular, Vall d'Hebron Research Institute, CIBBIM-Nanomedicine, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.
Antonio Pineda-LucenaLaboratorio de Bioquímica Estructural, Centro de Investigación Príncipe Felipe, Valencia, Spain.
José Raul HeranceGrup de Recerca en Imatge Mèdica Molecular, Vall d'Hebron Research Institute, CIBBIM-Nanomedicine, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0001-7178-3290
Centro de Investigacion Principe Felipe · ESUniversitat Autònoma de Barcelona · ESInstituto de Tecnología Química · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human peripheral blood cells are relevant ex vivo models for characterizing diseases and evaluating the pharmacological effects of therapeutic interventions, as they provide a close reflection of an individual pathophysiological state. In this work, a new approach to evaluate the impact of nanoparticles on the three main fractions of human peripheral blood cells by nuclear magnetic resonance spectroscopy is shown. Thus, a comprehensive protocol has been set-up including the separation of blood cells, their in vitro treatment with nanoparticles and the extraction and characterization of metabolites by nuclear magnetic resonance. This method was applied to assess the effect of gold nanoparticles, either coated with chitosan or supported on ceria, on peripheral blood cells from healthy individuals. A clear antioxidant effect was observed for chitosan-coated gold nanoparticles by a significant increase in reduced glutathione, that was much less pronounced for gold-cerium nanoparticles. In addition, the analysis revealed significant alterations of several other pathways, which were stronger for gold-cerium nanoparticles. These results are in accordance with the toxicological data previously reported for these materials, confirming the value of the current methodology.

Indexed as

GoldErythrocytesGlutathioneHumansLeukocytes, MononuclearMetabolomicsMetal NanoparticlesProton Magnetic Resonance SpectroscopyGlutathioneGold

Identifiers

PMID28793337
PMCPMC5549967
OpenAlexW4253805088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.